๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients

โœ Scribed by Maureen J. Lage; Beth L. Barber; Patrick L. McCollam; Mohan Bala; Joel Scherer


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
65 KB
Volume
52
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Impact of abciximab versus eptifibatide
โœ Maureen J. Lage; Beth L. Barber; Patrick L. McCollam; Mohan Bala; Joel Scherer ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 63 KB

## Abstract The purpose of this study is to compare the profile of percutaneous coronary intervention (PCI) patients who receive abciximab versus eptifibatide, as well as to compare the effect of abciximab versus eptifibatide on hospital length of stay. Retrospective data were obtained from HCIA's

A comparison of total hospital costs for
โœ Patrick L. McCollam; Maureen J. Lage; Mohan Bala ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB

## Abstract The purpose of this study was to examine the total hospital costs associated with the receipt of abciximab versus tirofiban for percutaneous coronary intervention (PCI) patients. Hospital billing data for patients with a primary procedure of PCI was examined for the period of July 1998

The impact of clinical trial protocols o
โœ Harold P. Freeman ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 464 KB ๐Ÿ‘ 2 views

Some Americans suffer a higher cancer incidence and mortality than those in mainstream American society, and, in general, do not enjoy the same health status. Black Americans, for example, have higher cancer incidence and lower survival rates than do white Americans. To date, there is no known genet